These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 21251323)

  • 1. EMT is the dominant program in human colon cancer.
    Loboda A; Nebozhyn MV; Watters JW; Buser CA; Shaw PM; Huang PS; Van't Veer L; Tollenaar RA; Jackson DB; Agrawal D; Dai H; Yeatman TJ
    BMC Med Genomics; 2011 Jan; 4():9. PubMed ID: 21251323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
    Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
    J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon cancer at the molecular level--usefulness of epithelial-mesenchymal transition analysis.
    Todosi AM; Gavrilescu MM; Aniţei GM; Filip B; Scripcariu V
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1106-11. PubMed ID: 23700897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative multi-omics analysis of a colon cancer cell line with heterogeneous Wnt activity revealed RUNX2 as an epigenetic regulator of EMT.
    Yi H; Li G; Long Y; Liang W; Cui H; Zhang B; Tan Y; Li Y; Shen L; Deng D; Tang Y; Mao C; Tian S; Cai Y; Zhu Q; Hu Y; Chen W; Fang L
    Oncogene; 2020 Jul; 39(28):5152-5164. PubMed ID: 32535615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer.
    Chien CW; Hou PC; Wu HC; Chang YL; Lin SC; Lin SC; Lin BW; Lee JC; Chang YJ; Sun HS; Tsai SJ
    Oncogene; 2016 Nov; 35(45):5872-5881. PubMed ID: 27132510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.
    Schell MJ; Yang M; Missiaglia E; Delorenzi M; Soneson C; Yue B; Nebozhyn MV; Loboda A; Bloom G; Yeatman TJ
    Clin Cancer Res; 2016 Feb; 22(3):734-45. PubMed ID: 26446941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells.
    Ning X; Wang C; Zhang M; Wang K
    Oncol Res; 2019 Mar; 27(4):399-406. PubMed ID: 29426374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.
    Ji M; Lee EJ; Kim KB; Kim Y; Sung R; Lee SJ; Kim DS; Park SM
    Oncol Rep; 2015 May; 33(5):2299-308. PubMed ID: 25813246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer.
    Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C
    FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
    Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
    Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR‑205 suppresses cell migration, invasion and EMT of colon cancer by targeting mouse double minute 4.
    Fan Y; Wang K
    Mol Med Rep; 2020 Aug; 22(2):633-642. PubMed ID: 32467998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer.
    Huang Z; Ai Z; Li N; Xi H; Gao X; Wang F; Tan X; Liu H
    Cancer Biomark; 2016; 17(4):445-455. PubMed ID: 28085015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
    Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
    Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
    Li Y; Zhao Z; Xu C; Zhou Z; Zhu Z; You T
    Cancer Lett; 2014 Dec; 355(1):130-40. PubMed ID: 25218351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol stimulates activation of Snail, epidermal growth factor receptor signaling, and biomarkers of epithelial-mesenchymal transition in colon and breast cancer cells.
    Forsyth CB; Tang Y; Shaikh M; Zhang L; Keshavarzian A
    Alcohol Clin Exp Res; 2010 Jan; 34(1):19-31. PubMed ID: 19860811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesis.
    Bhat AA; Pope JL; Smith JJ; Ahmad R; Chen X; Washington MK; Beauchamp RD; Singh AB; Dhawan P
    Oncogene; 2015 Aug; 34(35):4570-80. PubMed ID: 25500541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the mystery of colon cancer from the perspective of molecular subtypes and treatment.
    Lu W; Wang Q; Liu L; Luo W
    Sci Rep; 2024 May; 14(1):10883. PubMed ID: 38740818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor alpha promotes tumorigenesis and regulates epithelial-mesenchymal transition modulation in colon cancer.
    Yu CY; Chang WC; Zheng JH; Hung WH; Cho EC
    Biochem Biophys Res Commun; 2018 Dec; 506(4):901-906. PubMed ID: 30392905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between Tumor-Associated Dendritic Cells and Colon Cancer Cells Contributes to Tumor Progression via CXCL1.
    Hsu YL; Chen YJ; Chang WA; Jian SF; Fan HL; Wang JY; Kuo PL
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30115896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.